Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies
Sakari Santeri Rusanen, Suchetana De, Emmanuelle A. D. Schindler, Ville Artto, Markus Storvik
Current Pain and Headache Reports June 27, 2022 DOI: 10.1007/s11916-022-01063-5 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review Peer reviewed |
|---|---|
| Sample size | 5,419 |
| Population | Respondents from retrospective surveys on cluster headache treatments |
| Interventions | Oxygen subcutaneous triptan injections psilocybin lysergic acid diethylamide |
| Keywords | Pain medicine Cluster headache Cluster spacecraft Family medicine Physical therapy Migraine Anesthesiology |
| Citations | 12 |
| Key findings | Oxygen and subcutaneous triptan injections were most reported as effective abortive treatments, while psilocybin and LSD were most commonly reported as effective prophylactic treatments. |
Abstract
Abstract Purpose of Review The use and efficacy of various substances in the treatment of CH have been studied in several retrospective surveys. The aim of the study is to systematically review published survey studies to evaluate the reported efficacies of both established and unconventional substances in abortive and prophylactic treatment of both episodic and chronic CH, specifically assessing the consistency of the results. Recent Findings No systematic review have been conducted of these studies previously. A systematic literature search with a set of search terms was conducted on PubMed. Retrospective surveys that quantified the self-reported efficacy of two or more CH treatments, published in English during 2000–2020, were included. Several key characteristics and results of the studies were extracted. A total of 994 articles were identified of which 9 were found to be eligible based on the selection criteria. In total, 5419 respondents were included. Oxygen and subcutaneous triptan injections were most reported as effective abortive treatments, while psilocybin and lysergic acid diethylamide were most commonly reported as effective prophylactic treatments. The reported efficacy of most substances was consistent across different studies, and there were marked differences in the reported efficacies of different substances. The reported order of efficacy is generally in agreement with clinical studies. The findings suggest that retrospective surveys can be used to obtain supporting information on the effects of various substances used in the treatment of CH and to form hypotheses about novel treatment methods. The consistently reported efficacy of psilocybin and LSD in prophylactic treatment indicates need for clinical studies.
Citations in the library
Cited by 8
- Psilocybin for clinical indications: A scoping review Journal of Psychopharmacology August 13, 2024
- The possible place for psychedelics in pharmacotherapy of mental disorders. Pharmacological Reports December 1, 2023
- The historical opposition to psychedelic research and implications for credibility in psychiatry. CNS Spectrums November 21, 2024
- Associations between psychedelic use and migraine history in Swedish twins. Journal of Psychopharmacology May 1, 2026
- Patient perspectives on research gaps in cluster headache. Headache: The Journal of Head and Face Pain February 1, 2026
and 3 more in the library
Cites 12
- The pharmacology of psilocybin Addiction Biology October 1, 2002
- The Pharmacology of Lysergic Acid Diethylamide: A Review CNS Neuroscience & Therapeutics November 11, 2008
- Response of cluster headache to psilocybin and LSD Neurology June 26, 2006
- Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin. Neurotherapeutics 2021
- Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey Journal of Psychoactive Drugs October 20, 2015
and 7 more in the library